Der Einfluss einer vorbestehenden nicht alcoholic Leberverfettung auf die Lebertoxizität des Proteasomeninhibitors Bortezomib
S Neubert - 2023 - opus4.kobv.de
Mit der steigenden Prävalenz des metabolischen Syndroms in den Industrienationen ist
auch die Prävalenz der nicht alkoholischen Leberverfettung (Non-alcoholic fatty liver …
auch die Prävalenz der nicht alkoholischen Leberverfettung (Non-alcoholic fatty liver …
Aggravation des hépatopathies liées à l'obésité par les xénobiotiques
B Fromenty - Nutrition clinique et métabolisme, 2014 - Elsevier
Résumé Un nombre croissant d'investigations cliniques et expérimentales indique que
certains xénobiotiques peuvent aggraver les hépatopathies associées à l'obésité. En effet …
certains xénobiotiques peuvent aggraver les hépatopathies associées à l'obésité. En effet …
Drug-induced liver injury with cholestasis. Part 2: focus on antidiabetic drugs
OD Ostroumova, AP Pereverzev… - …, 2020 - pediatria.orscience.ru
Clinical use of some hypoglycemic drugs may be associated with the risk of drug-indiced
cholestatic liver damage (DILI). The exact prevalence of this complication is unknown …
cholestatic liver damage (DILI). The exact prevalence of this complication is unknown …
[HTML][HTML] Philippe Hantson
P Laterre - bioseek.eu
The case is reported of a 39-year-old severely obese woman who developed acute
metabolic disorders after the administration of a short course of intravenous amiodarone …
metabolic disorders after the administration of a short course of intravenous amiodarone …
[PDF][PDF] Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
S Sileno, RM Chirila, DM Harris - Romanian Journal of Internal …, 2020 - sciendo.com
Patients with chronic liver disease have associated comorbidities that require treatment,
including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These …
including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These …
Non-alkolik steatohepatitli ratlarda metformin, rosiglitazon, N-asetilsistein ve etodolakın tedavi edici etkilerinin değerlendirilmesi
S Yilmaz - 2010 - acikbilim.yok.gov.tr
Non alcoholic fatty liver disease (NAFLD), son yıllarda, en sık görülen karaciğer hastalığı
olması nedeniyle büyük önem kazanmıştır. Batı ülkelerinde, otopsi serilerindeki görülme …
olması nedeniyle büyük önem kazanmıştır. Batı ülkelerinde, otopsi serilerindeki görülme …
[PDF][PDF] ФАКУЛТЕТ МЕДИЦИНСКИХ НАУКА УНИВЕРЗИТЕТ У КРАГУЈЕВЦУ
Ј Јовановић - medf.kg.ac.rs
Акутна хепатотоксичност је један од највећих проблема фармаковигиланце. Дијагноза
овог нежељеног дејства би требало да се заснива на клиничким критеријумима али и …
овог нежељеног дејства би требало да се заснива на клиничким критеријумима али и …
[PDF][PDF] Cuidados especializados a la persona con congestión hepática
SSO Arreola, JCC Estrada… - Revista …, 2018 - …
Introducción: El hígado es un órgano que tiene múltiples funciones, tales como producir
bilis, proteínas, regular el metabolismo, almacenar vitaminas y glucosa, depurar la sangre …
bilis, proteínas, regular el metabolismo, almacenar vitaminas y glucosa, depurar la sangre …
[PDF][PDF] Hepatotoxic Effect of Intraperitoneal Administration of Amiodarone in Male Rabbits
The purpose of this study was to investigate the hepatotoxic effect of intraperitoneal
administration of amiodarone in male rabbits. Study was divided into 2 groups (control group …
administration of amiodarone in male rabbits. Study was divided into 2 groups (control group …